Logo image of CCEP.AS

COCA-COLA EUROPACIFIC PARTNE (CCEP.AS) Stock Fundamental Analysis

Europe - AMS:CCEP - GB00BDCPN049 - Common Stock

74.8 EUR
+0.6 (+0.81%)
Last: 10/6/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, CCEP scores 4 out of 10 in our fundamental rating. CCEP was compared to 26 industry peers in the Beverages industry. While CCEP is still in line with the averages on profitability rating, there are concerns on its financial health. CCEP is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CCEP was profitable.
In the past year CCEP had a positive cash flow from operations.
In the past 5 years CCEP has always been profitable.
Each year in the past 5 years CCEP had a positive operating cash flow.
CCEP.AS Yearly Net Income VS EBIT VS OCF VS FCFCCEP.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

Looking at the Return On Assets, with a value of 4.83%, CCEP is in the better half of the industry, outperforming 76.92% of the companies in the same industry.
The Return On Equity of CCEP (19.11%) is better than 76.92% of its industry peers.
CCEP's Return On Invested Capital of 7.78% is fine compared to the rest of the industry. CCEP outperforms 61.54% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CCEP is in line with the industry average of 8.66%.
Industry RankSector Rank
ROA 4.83%
ROE 19.11%
ROIC 7.78%
ROA(3y)5.14%
ROA(5y)4.27%
ROE(3y)19.29%
ROE(5y)16.02%
ROIC(3y)7.84%
ROIC(5y)6.6%
CCEP.AS Yearly ROA, ROE, ROICCCEP.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

The Profit Margin of CCEP (7.35%) is comparable to the rest of the industry.
CCEP's Profit Margin has declined in the last couple of years.
CCEP has a Operating Margin of 11.13%. This is in the lower half of the industry: CCEP underperforms 69.23% of its industry peers.
CCEP's Operating Margin has declined in the last couple of years.
The Gross Margin of CCEP (35.20%) is worse than 84.62% of its industry peers.
CCEP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.13%
PM (TTM) 7.35%
GM 35.2%
OM growth 3Y1.73%
OM growth 5Y-1.57%
PM growth 3Y-0.93%
PM growth 5Y-5.22%
GM growth 3Y-1.58%
GM growth 5Y-1.5%
CCEP.AS Yearly Profit, Operating, Gross MarginsCCEP.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CCEP is creating some value.
Compared to 1 year ago, CCEP has more shares outstanding
Compared to 5 years ago, CCEP has more shares outstanding
The debt/assets ratio for CCEP has been reduced compared to a year ago.
CCEP.AS Yearly Shares OutstandingCCEP.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
CCEP.AS Yearly Total Debt VS Total AssetsCCEP.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

An Altman-Z score of 2.04 indicates that CCEP is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.04, CCEP is in line with its industry, outperforming 46.15% of the companies in the same industry.
The Debt to FCF ratio of CCEP is 6.04, which is on the high side as it means it would take CCEP, 6.04 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.04, CCEP belongs to the top of the industry, outperforming 80.77% of the companies in the same industry.
A Debt/Equity ratio of 1.26 is on the high side and indicates that CCEP has dependencies on debt financing.
CCEP's Debt to Equity ratio of 1.26 is on the low side compared to the rest of the industry. CCEP is outperformed by 61.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF 6.04
Altman-Z 2.04
ROIC/WACC1.06
WACC7.37%
CCEP.AS Yearly LT Debt VS Equity VS FCFCCEP.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

CCEP has a Current Ratio of 0.83. This is a bad value and indicates that CCEP is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.83, CCEP is doing worse than 69.23% of the companies in the same industry.
A Quick Ratio of 0.65 indicates that CCEP may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.65, CCEP is in line with its industry, outperforming 53.85% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.65
CCEP.AS Yearly Current Assets VS Current LiabilitesCCEP.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

5

3. Growth

3.1 Past

CCEP shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.76%.
CCEP shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.80% yearly.
CCEP shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.04%.
Measured over the past years, CCEP shows a quite strong growth in Revenue. The Revenue has been growing by 11.21% on average per year.
EPS 1Y (TTM)-4.76%
EPS 3Y12.68%
EPS 5Y5.8%
EPS Q2Q%14.98%
Revenue 1Y (TTM)9.04%
Revenue growth 3Y14.09%
Revenue growth 5Y11.21%
Sales Q2Q%4.54%

3.2 Future

Based on estimates for the next years, CCEP will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.27% on average per year.
Based on estimates for the next years, CCEP will show a small growth in Revenue. The Revenue will grow by 3.63% on average per year.
EPS Next Y4.41%
EPS Next 2Y6.45%
EPS Next 3Y7.23%
EPS Next 5Y9.27%
Revenue Next Year2.25%
Revenue Next 2Y2.59%
Revenue Next 3Y3.04%
Revenue Next 5Y3.63%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CCEP.AS Yearly Revenue VS EstimatesCCEP.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
CCEP.AS Yearly EPS VS EstimatesCCEP.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 22.46 indicates a rather expensive valuation of CCEP.
CCEP's Price/Earnings ratio is a bit more expensive when compared to the industry. CCEP is more expensive than 61.54% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.90. CCEP is around the same levels.
The Price/Forward Earnings ratio is 16.47, which indicates a correct valuation of CCEP.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CCEP is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 23.36. CCEP is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 22.46
Fwd PE 16.47
CCEP.AS Price Earnings VS Forward Price EarningsCCEP.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CCEP's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. CCEP is more expensive than 69.23% of the companies in the same industry.
CCEP's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 17.16
EV/EBITDA 13.21
CCEP.AS Per share dataCCEP.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)5.09
PEG (5Y)3.87
EPS Next 2Y6.45%
EPS Next 3Y7.23%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.55%, CCEP has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.01, CCEP has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.44, CCEP has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.55%

5.2 History

On average, the dividend of CCEP grows each year by 9.91%, which is quite nice.
Dividend Growth(5Y)9.91%
Div Incr Years4
Div Non Decr Years4
CCEP.AS Yearly Dividends per shareCCEP.AS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

60.89% of the earnings are spent on dividend by CCEP. This is not a sustainable payout ratio.
The dividend of CCEP is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP60.89%
EPS Next 2Y6.45%
EPS Next 3Y7.23%
CCEP.AS Yearly Income VS Free CF VS DividendCCEP.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
CCEP.AS Dividend Payout.CCEP.AS Dividend Payout, showing the Payout Ratio.CCEP.AS Dividend Payout.PayoutRetained Earnings

COCA-COLA EUROPACIFIC PARTNE

AMS:CCEP (10/6/2025, 7:00:00 PM)

74.8

+0.6 (+0.81%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-05 2025-11-05
Inst Owners37.34%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap34.11B
Analysts77.27
Price Target86.76 (15.99%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.55%
Yearly Dividend1.98
Dividend Growth(5Y)9.91%
DP60.89%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.24%
PT rev (3m)3.46%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.57%
EPS NY rev (3m)-1.02%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-0.95%
Valuation
Industry RankSector Rank
PE 22.46
Fwd PE 16.47
P/S 1.63
P/FCF 17.16
P/OCF 11.66
P/B 4.25
P/tB N/A
EV/EBITDA 13.21
EPS(TTM)3.33
EY4.45%
EPS(NY)4.54
Fwd EY6.07%
FCF(TTM)4.36
FCFY5.83%
OCF(TTM)6.41
OCFY8.57%
SpS45.79
BVpS17.6
TBVpS-19.62
PEG (NY)5.09
PEG (5Y)3.87
Profitability
Industry RankSector Rank
ROA 4.83%
ROE 19.11%
ROCE 10.52%
ROIC 7.78%
ROICexc 8.57%
ROICexgc 51.16%
OM 11.13%
PM (TTM) 7.35%
GM 35.2%
FCFM 9.52%
ROA(3y)5.14%
ROA(5y)4.27%
ROE(3y)19.29%
ROE(5y)16.02%
ROIC(3y)7.84%
ROIC(5y)6.6%
ROICexc(3y)8.71%
ROICexc(5y)7.37%
ROICexgc(3y)64.53%
ROICexgc(5y)51.3%
ROCE(3y)10.42%
ROCE(5y)8.8%
ROICexcg growth 3Y8.99%
ROICexcg growth 5Y7.35%
ROICexc growth 3Y14.53%
ROICexc growth 5Y1.38%
OM growth 3Y1.73%
OM growth 5Y-1.57%
PM growth 3Y-0.93%
PM growth 5Y-5.22%
GM growth 3Y-1.58%
GM growth 5Y-1.5%
F-Score6
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF 6.04
Debt/EBITDA 3.08
Cap/Depr 98.22%
Cap/Sales 4.49%
Interest Coverage 9.37
Cash Conversion 89.23%
Profit Quality 129.6%
Current Ratio 0.83
Quick Ratio 0.65
Altman-Z 2.04
F-Score6
WACC7.37%
ROIC/WACC1.06
Cap/Depr(3y)92.36%
Cap/Depr(5y)78.04%
Cap/Sales(3y)4.17%
Cap/Sales(5y)3.92%
Profit Quality(3y)141.19%
Profit Quality(5y)162.2%
High Growth Momentum
Growth
EPS 1Y (TTM)-4.76%
EPS 3Y12.68%
EPS 5Y5.8%
EPS Q2Q%14.98%
EPS Next Y4.41%
EPS Next 2Y6.45%
EPS Next 3Y7.23%
EPS Next 5Y9.27%
Revenue 1Y (TTM)9.04%
Revenue growth 3Y14.09%
Revenue growth 5Y11.21%
Sales Q2Q%4.54%
Revenue Next Year2.25%
Revenue Next 2Y2.59%
Revenue Next 3Y3.04%
Revenue Next 5Y3.63%
EBIT growth 1Y2.97%
EBIT growth 3Y16.06%
EBIT growth 5Y9.46%
EBIT Next Year43.74%
EBIT Next 3Y17.22%
EBIT Next 5Y12.87%
FCF growth 1Y5.8%
FCF growth 3Y8.29%
FCF growth 5Y10.26%
OCF growth 1Y13.11%
OCF growth 3Y13.08%
OCF growth 5Y9.96%